- Institut Pasteur
- Nous soutenir
Post-doc position at Institut Pasteur, Paris, France.
Our group is developing two main projects related to the use of bacteriophages to target bacterial pathogens. The available position is linked to the project studying how virulent bacteriophages behave in the intestinal tract using animal models (see references below). Which parameters are influencing the activity of bacteriophages in such a complex environment is the main question covering both applied and fundamental aspects.
Ph.D. degree and training for animal work (preferably rodents) are mandatory. Experience in microbiology or immunology or metagenomic will be appreciated. The position will be open on 2014, January 1st with initial duration of 24 months and with possibilities of extension depending on future grants.
The field of Phage Therapy is very active as bacteriophages are a promising solution to combat antibiotic resistant pathogens. The first clinical trial supported by the European Commission and focusing on burn wound infections was indeed launched this summer. In addition, this renewed interest is also boosting research on basic aspect of the viral infection of microorganisms.
Institut Pasteur is a major international research institution providing a highly stimulating multidisciplinary scientific environment. Over 2000 people from various nationalities are working on the same site providing rapid and easy access to highly qualified colleagues and top-level equipment.
Please apply no later than November 1st by send CV, application letter, two recommendation letters, or questions to firstname.lastname@example.org
Département de Microbiologie
25 Rue du Dr Roux
75724 Paris Cedex 15
Maura D, Morello E, du Merle L, Bomme P, Le Bouguénec C, L. Debarbieux (2011) Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ. Microbiol. 14(8):1844-1854.
Maura D, Galtier M, Le Bouguénec C, Debarbieux L. (2012) Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob Agents Chemother. 56(12):6235-6242.